Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
46
BMED Quote, Financials, Valuation and Earnings
Last price:
$31.03
Seasonality move
:
-3.59%
Day range:
$30.31 - $30.45
52-week range:
$20.57 - $32.19
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
2.8K
Avg. volume:
7.7K
1-year change:
19.91%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
HRTS
Tema Heart & Health ETF
|
-- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- |
|
TMED
Trimedyne
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
$30.45 | -- | -- | -- | $0.01 | 0% | -- |
|
AGNG
Global X Aging Population ETF
|
$37.36 | -- | -- | -- | $0.17 | 0.84% | -- |
|
HRTS
Tema Heart & Health ETF
|
$35.50 | -- | -- | -- | $0.47 | 1.33% | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
$35.15 | -- | -- | -- | $0.35 | 0.99% | -- |
|
TMED
Trimedyne
|
-- | -- | -- | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
-- | 0.614 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 0.225 | -- | -- |
|
HRTS
Tema Heart & Health ETF
|
-- | 0.247 | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | 0.901 | -- | -- |
|
TMED
Trimedyne
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
HRTS
Tema Heart & Health ETF
|
-- | -- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- | -- |
|
TMED
Trimedyne
|
-- | -- | -- | -- | -- | -- |
iShares Health Innovation Active ETF vs. Competitors
-
Which has Higher Returns BMED or AGNG?
Global X Aging Population ETF has a net margin of -- compared to iShares Health Innovation Active ETF's net margin of --. iShares Health Innovation Active ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEDiShares Health Innovation Active ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About BMED or AGNG?
iShares Health Innovation Active ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Health Innovation Active ETF has higher upside potential than Global X Aging Population ETF, analysts believe iShares Health Innovation Active ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEDiShares Health Innovation Active ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is BMED or AGNG More Risky?
iShares Health Innovation Active ETF has a beta of 0.892, which suggesting that the stock is 10.827% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.142%.
-
Which is a Better Dividend Stock BMED or AGNG?
iShares Health Innovation Active ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Global X Aging Population ETF offers a yield of 0.84% to investors and pays a quarterly dividend of $0.17 per share. iShares Health Innovation Active ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMED or AGNG?
iShares Health Innovation Active ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. iShares Health Innovation Active ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, iShares Health Innovation Active ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Health Innovation Active ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEDiShares Health Innovation Active ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns BMED or HRTS?
Tema Heart & Health ETF has a net margin of -- compared to iShares Health Innovation Active ETF's net margin of --. iShares Health Innovation Active ETF's return on equity of -- beat Tema Heart & Health ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEDiShares Health Innovation Active ETF-- -- -- HRTSTema Heart & Health ETF-- -- -- -
What do Analysts Say About BMED or HRTS?
iShares Health Innovation Active ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema Heart & Health ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Health Innovation Active ETF has higher upside potential than Tema Heart & Health ETF, analysts believe iShares Health Innovation Active ETF is more attractive than Tema Heart & Health ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEDiShares Health Innovation Active ETF0 0 0 HRTSTema Heart & Health ETF0 0 0 -
Is BMED or HRTS More Risky?
iShares Health Innovation Active ETF has a beta of 0.892, which suggesting that the stock is 10.827% less volatile than S&P 500. In comparison Tema Heart & Health ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BMED or HRTS?
iShares Health Innovation Active ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Tema Heart & Health ETF offers a yield of 1.33% to investors and pays a quarterly dividend of $0.47 per share. iShares Health Innovation Active ETF pays -- of its earnings as a dividend. Tema Heart & Health ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMED or HRTS?
iShares Health Innovation Active ETF quarterly revenues are --, which are smaller than Tema Heart & Health ETF quarterly revenues of --. iShares Health Innovation Active ETF's net income of -- is lower than Tema Heart & Health ETF's net income of --. Notably, iShares Health Innovation Active ETF's price-to-earnings ratio is -- while Tema Heart & Health ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Health Innovation Active ETF is -- versus -- for Tema Heart & Health ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEDiShares Health Innovation Active ETF-- -- -- -- HRTSTema Heart & Health ETF-- -- -- --
-
Which has Higher Returns BMED or HTEC?
ROBO Global Healthcare Technology & Innovation ETF has a net margin of -- compared to iShares Health Innovation Active ETF's net margin of --. iShares Health Innovation Active ETF's return on equity of -- beat ROBO Global Healthcare Technology & Innovation ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEDiShares Health Innovation Active ETF-- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -
What do Analysts Say About BMED or HTEC?
iShares Health Innovation Active ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ROBO Global Healthcare Technology & Innovation ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Health Innovation Active ETF has higher upside potential than ROBO Global Healthcare Technology & Innovation ETF, analysts believe iShares Health Innovation Active ETF is more attractive than ROBO Global Healthcare Technology & Innovation ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEDiShares Health Innovation Active ETF0 0 0 HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 -
Is BMED or HTEC More Risky?
iShares Health Innovation Active ETF has a beta of 0.892, which suggesting that the stock is 10.827% less volatile than S&P 500. In comparison ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.227, suggesting its more volatile than the S&P 500 by 22.745%.
-
Which is a Better Dividend Stock BMED or HTEC?
iShares Health Innovation Active ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. ROBO Global Healthcare Technology & Innovation ETF offers a yield of 0.99% to investors and pays a quarterly dividend of $0.35 per share. iShares Health Innovation Active ETF pays -- of its earnings as a dividend. ROBO Global Healthcare Technology & Innovation ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMED or HTEC?
iShares Health Innovation Active ETF quarterly revenues are --, which are smaller than ROBO Global Healthcare Technology & Innovation ETF quarterly revenues of --. iShares Health Innovation Active ETF's net income of -- is lower than ROBO Global Healthcare Technology & Innovation ETF's net income of --. Notably, iShares Health Innovation Active ETF's price-to-earnings ratio is -- while ROBO Global Healthcare Technology & Innovation ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Health Innovation Active ETF is -- versus -- for ROBO Global Healthcare Technology & Innovation ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEDiShares Health Innovation Active ETF-- -- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- --
-
Which has Higher Returns BMED or TMED?
Trimedyne has a net margin of -- compared to iShares Health Innovation Active ETF's net margin of --. iShares Health Innovation Active ETF's return on equity of -- beat Trimedyne's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEDiShares Health Innovation Active ETF-- -- -- TMEDTrimedyne-- -- -- -
What do Analysts Say About BMED or TMED?
iShares Health Innovation Active ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Trimedyne has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Health Innovation Active ETF has higher upside potential than Trimedyne, analysts believe iShares Health Innovation Active ETF is more attractive than Trimedyne.
Company Buy Ratings Hold Ratings Sell Ratings BMEDiShares Health Innovation Active ETF0 0 0 TMEDTrimedyne0 0 0 -
Is BMED or TMED More Risky?
iShares Health Innovation Active ETF has a beta of 0.892, which suggesting that the stock is 10.827% less volatile than S&P 500. In comparison Trimedyne has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BMED or TMED?
iShares Health Innovation Active ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Trimedyne offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iShares Health Innovation Active ETF pays -- of its earnings as a dividend. Trimedyne pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMED or TMED?
iShares Health Innovation Active ETF quarterly revenues are --, which are smaller than Trimedyne quarterly revenues of --. iShares Health Innovation Active ETF's net income of -- is lower than Trimedyne's net income of --. Notably, iShares Health Innovation Active ETF's price-to-earnings ratio is -- while Trimedyne's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Health Innovation Active ETF is -- versus -- for Trimedyne. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEDiShares Health Innovation Active ETF-- -- -- -- TMEDTrimedyne-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
42
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
93
NBTX alert for Mar 5
Nanobiotix SA [NBTX] is down 5.93% over the past day.
Sell
45
MRNA alert for Mar 5
Moderna, Inc. [MRNA] is down 6.85% over the past day.
Buy
77
SSRM alert for Mar 5
SSR Mining, Inc. [SSRM] is down 6.52% over the past day.
